Category: clinical study retractions

Karolinska told a journal to retract a paper by Macchiarini. It refused. The story didn’t end there.

The president of the Karolinska Institutet (KI) is frustrated.

At the beginning of the year, Ole Petter Ottersen informed a journal that one of its papers — co-authored by former superstar Paolo Macchiarini — had been tainted by misconduct. But the journal declined to retract it.

Despite the fact that KI had conducted its own investigation into the integrity of the paper, the journal Respiration argued that it was “not in a position to make a judgement on whether or not to retract this article.” Instead, it proposed publishing KI’s argument for why the paper should be retracted, along with a rebuttal from the authors.

To Ottersen, this is just wrong. Yesterday, he posted some of his correspondence with the journal, which includes his request for retraction, the journal’s response, and his rebuttal. Ottersen’s blog post concludes:

Continue reading Karolinska told a journal to retract a paper by Macchiarini. It refused. The story didn’t end there.

How much cancer stems from diabetes, obesity? Lancet journal swaps high-profile paper

Six months ago, the media was ablaze with the findings of a new paper, showing that nearly six percent of cancer cases are caused, at least in part, by obesity and diabetes. But this week, the journal retracted that paper — and replaced it with a revised version.

The new paper doesn’t change the main findings much — the share of all cancers attributable to diabetes and obesity changed from 5.6% to 5.7%, which wouldn’t change any headlines about the original paper. But soon after the paper was published, a group of researchers noticed the authors’ mistake — which was significant enough to prompt the journal to retract the paper entirely, and swap it with a new one.

According to first author Jonathan Pearson-Stuttard at Imperial College London:

Continue reading How much cancer stems from diabetes, obesity? Lancet journal swaps high-profile paper

Dental journal pulls a dozen papers for recycled images and “unreliable data”

A leading orthodontics journal has retracted 12 papers after determining that they contained either reused images, questionable data or both. Several of the articles involved experiments conducted in dogs — and one person familiar with the case told us that the duplication was an attempt to avoid sacrificing more animals than necessary for the research.  

Although the list of authors on the articles varies, the common denominator is Jose Luis Calvo-Guirado, of the UCAM Universidad Católica San Antonio de Murcia, in Spain. Calvo-Guirado’s title at the institution is director de la Cátedra Internacional de Investigación en Odontología, which Google translates as director of the International Research Chair in Dentistry.  Calvo-Guirado also holds (or has held) a research professorship at SUNY Stony Brook in the Department of Prosthodontics and Digital Medicine, according to his CV.

Calvo-Guirado’s name is on at least 187 entries in PubMed. Of those, 40 appeared in Clinical Oral Implants Research, a Wiley title on whose editorial board the researcher served, according to his CV.  

Continue reading Dental journal pulls a dozen papers for recycled images and “unreliable data”

Hey journals, it is possible to quickly correct the record

Even when a paper is obviously flawed, it can take years for journals to take action. Some never do. But it doesn’t have to be that way.

On April 27, a reader emailed the editors of two journals, noting that each had recently published a paper by the same group of authors that appeared strikingly similar.

Four days later, on May 1, a representative at Medicine, the journal that published the most recent version of the paper, wrote the reader back, saying the paper was going to be retracted.

Continue reading Hey journals, it is possible to quickly correct the record

Caught Our Notice: A paper mistakenly ID’d a patient. Its retraction notice did, too. (Oops!)

What Caught Our Attention: Last year, a journal retracted a paper about a child who developed a rare complication related to the inherited disorder Gaucher Disease, after realizing it had inadvertently identified the child. It wasn’t an immediately obvious mistake — the authors listed the drugs the patient was taking, and in the case of one drug, there was only one child in the world taking it. For anyone in the know, that would make the child’s identity clear.

So retracting the paper makes sense — but publishing a retraction notice that spells out the issue in detail, including the name of the drug and the fact the patient was the only pediatric recipient, did not. So last month, the Journal of Pediatric Hematology/Oncology corrected the retraction notice, removing the name of the drug. (Phew.)

Continue reading Caught Our Notice: A paper mistakenly ID’d a patient. Its retraction notice did, too. (Oops!)

A distorted record on blood pressure drugs: Why one group is trying to clean up the literature

In 2015, a group of researchers based in Spain decided to write a review article on high blood pressure. But when they looked over eight articles co-authored by the same person, they noticed some undeniable similarities.

Over the last few years, Giuseppe Derosa, based at the University of Pavia in Italy, has racked up 10 retractions after journals determined he’d published the same material multiple times. But there’s much more to this story: The researchers in Spain (led by Luis Carlos Saiz of the Navarre Regional Health Service in Pamplona) kept digging into his publication record, and have since identified dozens of additional potential duplicates. Although the outside researchers alerted journals to the additional potentially problematic papers in 2015, most have not taken action; recently, two journals published by Taylor & Francis flagged 12 of Derosa’s articles, three of which they had been alerted about in 2015 by Saiz and colleagues.

Now, Saiz is telling his story — and why duplication of medical research matters:

Continue reading A distorted record on blood pressure drugs: Why one group is trying to clean up the literature

Infighting at journal prompts retraction of editorial “full of misinformation”

An editor thought she did a great job running an anesthesiology journal. But her colleagues— including the new editor who took over for her—heartily disagree.

During her tenure at the journal, the outgoing editor penned an editorial taking credit for the journal’s rise to success. But, according to a new commentary published in the journal, the former editor’s article presented wrong statistics, and minimized the contributions of those who had come before her. So when the new editor took office, he retracted it—and published the lengthy commentary explaining why. Continue reading Infighting at journal prompts retraction of editorial “full of misinformation”

Nutrition paper claims intervention cuts child obesity. Experts disagree.

Does incorporating gardens and their harvest into school-based nutrition programs help children get healthier? A 2017 paper claims it does, but a group of outside experts disagrees — strongly.

The 2017 paper reported that adding gardens to schools and teaching kids how to cook the harvest, among other elements, helped kids learn about nutrition — and even improved their body mass index, a measure of body weight.

However, soon after the paper appeared, a group of outside experts told the journal the data reported by the paper didn’t support its conclusions — namely, the authors hadn’t shown that the intervention had any effect. The authors performed an inappropriate analysis of the data, the critics claimed, and the paper needed to be either corrected or retracted outright.

But the Journal of Nutrition Education and Behavior has not amended the paper in any way. Instead, last month, it published the outside experts’ criticism of the paper, including their explicit calls to either correct or retract it, along with the authors’ response to the critics.

David Allison, the last author on the critical letter and the dean of the school of public health at Indiana University Bloomington, said he was surprised to see the journal chose to publish his critical letter, but not alter the paper itself:

Continue reading Nutrition paper claims intervention cuts child obesity. Experts disagree.

“Youth Guru” loses turkey-neck paper that overlapped with book chapter

Ronald Moy

A prominent cosmetic surgeon and his daughter have lost a 2017 paper on treating men with excessive neck flab — otherwise known as “turkey neck” — because much of the work appears to have duplicated a book chapter he co-authored about the topic.

The first author of the retracted article is Ronald L. Moy, a plastic surgeon to the stars in Beverly Hills, Calif., and a past president of both the American Academy of Dermatology and the American Society of Dermatology. In a 2012 article about area plastic surgeons, LA Confidential Magazine dubbed Moy the “youth guru” and a local leader in the use of “new research and a comprehensive approach to restore a youthful complexion—no cutting required.”

His co-author was his daughter, Lauren Moy, who appears to be working with him in his Rodeo Drive dermatology practice.

Continue reading “Youth Guru” loses turkey-neck paper that overlapped with book chapter

Caught Our Notice: Forged email for corresponding author dooms diabetes paper

Title: Naringin Alleviates Diabetic Kidney Disease through Inhibiting Oxidative Stress and Inflammatory Reaction

What Caught Our Attention: PLOS ONE had a few reasons for retracting a 2015 paper about a treatment for kidney disease due to diabetes: For one, despite what the paper claims, the authors did not obtain ethical approval to conduct the reported animal experiments. In addition, the corresponding author had no idea the paper had been submitted and published. How could a corresponding author be kept in the dark? It turns out, the journal was given an incorrect email address for him, so he didn’t receive any communications around the paper. (One author apparently used a third party editing company.) Continue reading Caught Our Notice: Forged email for corresponding author dooms diabetes paper